Literature DB >> 30132010

Combined transcranial direct current stimulation and breathing-controlled electrical stimulation for management of neuropathic pain after spinal cord injury.

Shengai Li1, Argyrios Stampas, Joel Frontera, Matthew Davis, Sheng Li.   

Abstract

OBJECTIVE: To determine whether transcranial direct current stimulation augments the analgesic effect of breathing-controlled electrical stimulation in patients with spinal cord injury who have chronic neuropathic pain.
DESIGN: Sham-controlled, single-blinded, single-centre, cross-over study of 12 participants with incomplete spinal cord injury. The treatment protocol included a 20-min transcranial direct current stimulation (sham or active), followed by a 20-min breathing-controlled electrical stimulation to the median nerve on the dominant side. The treatment session with sham or control transcranial direct current stimulation was given on different days in a randomized order. Visual analogue scale was used to assess neuropathic pain at baseline, 10 min after transcranial direct current stimulation, and 10 min after breathing-controlled electrical stimulation.
RESULTS: Participants were blinded to the status of transcranial direct current stimulation. Out of the 12 participants, 10 completed sessions of both sham and active transcranial direct current stimulation, while the other 2 completed only active transcranial direct current stimulation and breathing-controlled electrical stimulation treatment. Out of the 12 participants, 7 showed analgesic effects after active transcranial direct current stimulation, while sham transcranial direct current stimulation produced some analgesic effects in 4 out of 10 participants. At the group level, there was no difference between active and sham transcranial direct current stimulation treatment. All except one participant responded positively to breathing-controlled electrical stimulation in all sessions. Visual analogue scale score for pain decreased significantly after breathing-controlled electrical stimulation combined with either active transcranial direct current stimulation or sham transcranial direct current stimulation treatment.
CONCLUSION: The immediate analgesic effect of breathing-controlled electrical stimulation was confirmed. However, this effect was not augmented after one session of transcranial direct current stimulation treatment.

Entities:  

Mesh:

Year:  2018        PMID: 30132010     DOI: 10.2340/16501977-2379

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  4 in total

1.  Transcranial Direct Current Stimulation and Mirror Therapy for Neuropathic Pain After Brachial Plexus Avulsion: A Randomized, Double-Blind, Controlled Pilot Study.

Authors:  Clarice Martins Ferreira; Carolina Dias de Carvalho; Ruth Gomes; Erickson Duarte Bonifácio de Assis; Suellen Marinho Andrade
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

2.  Physiotherapy interventions may relieve pain in individuals with central neuropathic pain: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Priya Kannan; Umar Muhammad Bello; Stanley John Winser
Journal:  Ther Adv Chronic Dis       Date:  2022-03-24       Impact factor: 5.091

Review 3.  Methods and strategies of tDCS for the treatment of pain: current status and future directions.

Authors:  Kevin Pacheco-Barrios; Alejandra Cardenas-Rojas; Aurore Thibaut; Beatriz Costa; Isadora Ferreira; Wolnei Caumo; Felipe Fregni
Journal:  Expert Rev Med Devices       Date:  2020-09-15       Impact factor: 3.166

4.  Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders.

Authors:  Felipe Fregni; Mirret M El-Hagrassy; Kevin Pacheco-Barrios; Sandra Carvalho; Jorge Leite; Marcel Simis; Jerome Brunelin; Ester Miyuki Nakamura-Palacios; Paola Marangolo; Ganesan Venkatasubramanian; Daniel San-Juan; Wolnei Caumo; Marom Bikson; André R Brunoni
Journal:  Int J Neuropsychopharmacol       Date:  2021-04-21       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.